Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria

Abstract

Background: Chronic urticaria is a highly distressing disease affecting a person’s quality of life. In most cases, monotherapy fails. Hence, combinations of antihistamines with montelukast, H2 blockers, ciclosporin, dapsone, omalizumab are used with varying results. This study was done to assess the efficacy and safety of the combination therapy of Montelukast and Cetirizine with Ranitidine and Cetirizine in chronic urticaria patients . Methodology: In this randomized controlled study, hundred patients were recruited, randomized and medications were given to group A (Cetirizine + Montelukast) and group B (Cetirizine + Ranitidine). Complete history, clinical examination and laboratory investigations were done at the beginning of the study. Patients were educated to keep a daily record of Urticaria Activity Score (UAS7) over seven consecutive days in a descriptive chart. Review of patient’s UAS7 record and clinical examination were done at every weekend. Sum of score at the end of every week for 4 weeks were calculated and recorded. Results: The mean weekly UAS in group A were 18.67, 10.07, 4.65, and 1.74 and in group B were 27.77, 19.38, 13.68 and 8.04 respectively. Significant difference in symptom reduction between group A and group B was found to be favouring group A. The mean total UAS in group A was 35.13, group B is 68.87 (p < 0.001). Conclusion: Montelukast seems to be a promising medication as add-on therapy to Cetirizine both in the aspect of efficacy and safety in patients affected by chronic urticaria.

Authors and Affiliations

Sivagami Dinesh

Keywords

Related Articles

PAR-2-Mediated Relaxation of Rectum is Impaired Following Bacillary Dysentery in Rat

Background: PAR-2 activation modifies the intestinal motility and takes part in gastrointestinal motility disturbances under intestinal infection or inflammation, but its role in the regulation of normal rectum motility...

Drug-Induced Delirium from a Suspected Drug-Drug Interaction between Promethazine and Ketorolac

Case: An 18 year old female with no psychiatric history experiences delirium following the administration of promethazine and ketorolac which resolves following the discontinuation of both medications. The pathophysiolog...

CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly Based on Nonparametric Population Pharmacokinetic Modeling and Simulations

Objective: The primary aim of this article is to test the hypothesis that nonparametric pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on data from a study that reported results based on...

Toxic Compounds Analysis by High Performance Liquid Chromatography

Toxic Compounds Analysis by High Performance Liquid Chromatography

Evaluation of Health Related Quality of Life in Patient with Oral Cavity Squamous Cell Carcinoma Receiving Chemotherapy

Objective: To evaluate impact of chemotherapy on Health Related Quality of Life (HRQOL) in patients of oral cavity squamous cell carcinoma (OCSCC) by analysis of two different treatments named Concurrent Chemo - Radiatio...

Download PDF file
  • EP ID EP529988
  • DOI 10.19070/2167-910X-1800048
  • Views 80
  • Downloads 0

How To Cite

Sivagami Dinesh (2018). Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria. International Journal of Clinical Pharmacology & Toxicology(IJCPT), 7(1), 290-295. https://europub.co.uk/articles/-A-529988